Post-eradication poliovirus facility-associated community risks

作者: Walter R. Dowdle , Chris Wolff

DOI: 10.1016/J.BIOLOGICALS.2006.03.003

关键词:

摘要: Minimizing the risk of poliovirus transmission from facility to an increasingly susceptible community is crucial when global and OPV use stops. Community risks exposure wild as well Sabin strains are highest personnel who unknowingly contaminated or infected. Immunization with IPV prevents poliomyelitis, but neither vaccine fully inhibits silent infection gut. Facility environments maintained at low relative humidity (<50%) may reduce survival inhalation risk. Circulating antibodies injection virus entry through breaks in skin mucous membranes. air effluent likely most modern facilities. ingestion liquid effluents facility-specific range high low. This assessment risks, combined assessments hazards consequences transmission, provides foundation for effective management.

参考文章(18)
Craig Wallis, Charles P. Gerba, Joseph L. Melnick, Viruses in water. Bulletin of The World Health Organization. ,vol. 56, pp. 499- 508 ,(1978)
Glen J. Dixon, Robert W. Sidwell, Ethel Mcneil, Quantitative Studies on Fabrics as Disseminators of Viruses Applied Microbiology. ,vol. 14, pp. 183- 188 ,(1966) , 10.1128/AM.14.2.183-188.1966
Hilary Koprowski, IMMUNIZATION OF INFANTS WITH LIVING ATTENUATED POLIOMYELITIS VIRUS Journal of the American Medical Association. ,vol. 162, pp. 1281- 1288 ,(1956) , 10.1001/JAMA.1956.02970310009003
J. C. de Jong, M. Harmsen, T. Trouwborst, The infectivity of the nucleic acid of aerosol-inactivated poliovirus. Journal of General Virology. ,vol. 18, pp. 83- 86 ,(1973) , 10.1099/0022-1317-18-1-83
W. R. Dowdle, M. E. Birmingham, The Biologic Principles of Poliovirus Eradication The Journal of Infectious Diseases. ,vol. 175, ,(1997) , 10.1093/INFDIS/175.SUPPLEMENT_1.S286
J G Yeager, R T O'Brien, Enterovirus inactivation in soil. Applied and Environmental Microbiology. ,vol. 38, pp. 694- 701 ,(1979) , 10.1128/AEM.38.4.694-701.1979
D L Sewell, Laboratory-associated infections and biosafety. Clinical Microbiology Reviews. ,vol. 8, pp. 389- 405 ,(1995) , 10.1128/CMR.8.3.389